Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis

Abstract Background Transthyretin cardiac amyloidosis, also known as transthyretin cardiomyopathy (ATTR-CM) is a poorly-recognized disease with delayed diagnosis and poor prognosis. This nationwide population-based study aimed to identify disease manifestations, economic burden, and mortality of pat...

Full description

Bibliographic Details
Main Authors: Suk-Chan Jang, Jin Hyun Nam, Seung-Ah Lee, Dasom An, Hye-Lin Kim, Sun-Hong Kwon, Eui-Kyung Lee
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Orphanet Journal of Rare Diseases
Subjects:
ATTR-CM
Cardiac amyloidosis
Economic burden
Heart failure
Survival rates
Online Access:https://doi.org/10.1186/s13023-022-02425-3

Internet

https://doi.org/10.1186/s13023-022-02425-3

Similar Items